UnitedHealth Group (NYSE:UNH) Announces FY 2026 Earnings Guidance

UnitedHealth Group (NYSE:UNH) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 20.500- for the period, compared to the consensus earnings per share estimate of 19.860.

Wall Street Analyst Weigh In

A number of brokerages have commented on UNH. Evercore upped their price objective on UnitedHealth Group from $400.00 to $480.00 and gave the company an “outperform” rating in a report on Tuesday, July 7th. Truist Financial lifted their target price on UnitedHealth Group from $440.00 to $480.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Oppenheimer raised their price target on shares of UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a research report on Friday, July 17th. Mizuho lifted their price objective on shares of UnitedHealth Group from $470.00 to $493.00 and gave the stock an “outperform” rating in a research note on Monday, July 20th. Finally, Barclays increased their target price on shares of UnitedHealth Group from $429.00 to $441.00 and gave the stock an “overweight” rating in a research report on Monday, July 20th. Twenty equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $462.59.

UnitedHealth Group Price Performance

Shares of UNH traded up $0.07 during trading hours on Tuesday, hitting $378.59. 12,633,109 shares of the company were exchanged, compared to its average volume of 7,378,446. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The company has a market cap of $339.82 billion, a price-to-earnings ratio of 24.36, a P/E/G ratio of 1.43 and a beta of 0.60. The firm’s fifty day moving average is $387.44 and its 200 day moving average is $382.57.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%. The business’s revenue was down .4% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts anticipate that UnitedHealth Group will post 19.85 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio is 59.72%.

Insider Activity

In related news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.19% of the company’s stock.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 earnings beat expectations: Adjusted earnings were $4.69 per share versus consensus estimates near $4.12–$4.14, while revenue of approximately $112.7 billion also topped forecasts. Operating earnings jumped 52% to $6.6 billion. UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs
• Positive Sentiment: Improved medical-cost performance: Lower medical costs, better margins and tighter operating discipline lifted profit substantially from the prior-year quarter. Management said its turnaround strategy, including exiting or reducing unprofitable business, is improving profitability. UNH Tops Q3 Earnings on Lower Medical Costs, Raises 2026 Outlook
• Positive Sentiment: Higher 2026 outlook and constructive 2027 commentary: UnitedHealth raised its 2026 adjusted earnings guidance to at least $20.50 per share, and executives indicated that consensus forecasts for 2027 may be too conservative. Management is targeting 13%–16% long-term earnings growth as operations recover. UnitedHealth Says Wall Street May Be Underestimating Its 2027 Earnings Potential
• Positive Sentiment: Medicaid margin recovery anticipated: Management described 2026 as a likely bottom for core Medicaid margins and expects improvement after that point, supporting the case for stronger earnings beyond 2026. UnitedHealth Calls 2026 the Bottom for Medicaid Margins
• Neutral Sentiment: Technology and efficiency initiatives are progressing: UnitedHealth said artificial-intelligence tools reduced clinical review times by roughly 33%, while Optum continues expanding pharmacy and value-based-care services. These efforts could support margins, but their financial impact remains developing.
• Negative Sentiment: Revenue growth remains limited and investor reaction cooled: Quarterly sales were essentially flat or slightly lower year over year, and Optum Health revenue slipped. Shares reversed part of their early rally, suggesting that investors may have expected an even stronger outlook or were concerned that elevated medical costs and mixed healthcare-sector results remain risks.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.